Schneider Phillip M

Schneider Phillip M is listed in filings as Director at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 27, 2025, including 6 public disclosures. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY) and Longboard Pharmaceuticals, Inc. (LBPH). The current snapshot covers public activity from Jun 24, 2024 to Jun 27, 2025. Reported amounts are shown as $309.2K to $426.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.